Under the company AUMED, a.s. also include AUMED Immunology a.s. and AUMED Pharma a.s., which were founded with their own business goals. You can learn more about these companies and their goals here:

Excessive use of antibiotics in healthcare has led to the rise of multi-resistant and pan-resistant strains of bacteria. This has created a serious problem in the field of veterinary and human medicine in the fight against infectious diseases. The same problem are residues in foods that have a negative impact on human health, especially negative for the immune system. Today’s interest is mainly in non-antibiotic and non-generic preparations based on bacteriophage probiotics and enzyme therapy.

Research and subsequent implementation in these areas would reduce the waste burden on the environment, have a positive impact on regional growth and create new jobs with the possibility of involving university students.

TRANSFER FACTOR

Research and development of transfer factors intended for human therapy.

ATOPIC ECZEMA

Development of a preparation based on a cleansing spray intended for the supportive treatment of the skin in case of atopic eczema.

AUMED, a.s. solves research projects in the field of bacterial vaccines (pertussis vaccine – Bordetella pertussis) and immunomodulators (transfer factor innovation).

In addition to its own research and development activities, it uses its expertise for consulting, advisory and training activities for external entities. These are highly specified pharmaceutical professional activities with an emphasis on GMP (Good Manufacturing Practice), which are actively required by external companies.

References:

Hematology and Blood Transfusion Institute – training and expert activities of AUMED a.s. personnel concerning the implementation of GMP in the area of ATMP (Advanced Therapy Medicinal Products). Consultations with SÚKL. Company audits participation.

Institutul Pasteur Romania – experts activities concerning the construction project of a new manufacturing areal for pharmaceutical manufacture.

Co Antigen Ltd, Research and Prouction Center the Republic of Kazakhstan, Almaty – expert activities concerning the implementation of GMP in pharmaceutical manufacture. Personnel training. Practical training. Representation before government authority.

EBRD – European Bank for Reconstruction and Development – AUMED a.s. personnel are registered as expert counsel to the bank in the area of pharmaceutical issues for small companies. For this purpose, they are being retained by the Bank of London for specific projects realized by the bank abroad.

ICRC (International Clinical Research Center St. Anne’s Faculty – consultancy activities for the implementation of GMP in the entire process – specifically, project participation, construction realization consultation, technological assembly implementation, validation issues, documents creation, personnel training etc.

Macromolecular Chemistry Institute AV ČR – BIOCEV department – (Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec). Consultancy activities for the implementation of GMP in the entire process – specifically, project participation, SÚK project consultation, construction realization consultation, technological assembly implementation, validation issues, documents creation, personnel training etc.